Israeli human tissue repair company CollPlant is shortly to list on NASDAQ. Collplant uses tobacco plant DNA to develop and manufacture collagen-based regenerative medical treatments and bio-ink used in 3D printing of human tissues and organs.
http://www.calcalistech.com/ctech/articles/0,7340,L-3730753,00.html